Regulation of hexokinase II expression in human skeletal muscle in vivo

C. Vogt, H. Ardehali, P. Iozzo, H. Yki-Jarvinen, J. Koval, K. Maezono, M. Pendergrass, R. Printz, D. Granner, R. DeFronzo, L. Mandarino

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The phosphorylation of glucose to glucose-6-phosphate (G-6-P) is the first committed step in glucose uptake in skeletal muscle. This reaction is catalyzed by hexokinase (HK). Two HK isoforms, HKI and HKII, are expressed in human skeletal muscle, but only HKII is regulated by insulin. The present study was undertaken to determine the time course for the regulation of HK activity and expression by physiological plasma insulin concentrations in human skeletal muscle in vivo. A hyperinsulinemic-euglycemic glucose clamp and percutaneous muscle biopsy were performed in separate groups of healthy subjects after 60, 120, 180, and 360 minutes of euglycemic hyperinsulinemia. Muscle biopsies were subfractionated into soluble and particulate fractions to determine HKI and HKII activities. RNA was extracted from a separate portion of the muscle biopsy, and HKI and HKII mRNA content was determined using an RNase protection assay. Glycogen synthase (GS) activity and fractional velocity were also determined. HKII mRNA was increased 2-fold by 120 minutes and remained high versus the basal value for up to 360 minutes. HKI mRNA was unchanged throughout the study. HKII activity increased after 360 minutes of insulin infusion, and this increase was limited to the soluble fraction. In contrast, insulin induced a 1.5- to 2-fold increase in GS fractional velocity that was sustained for 360 minutes. The time course of the ability of hyperinsulinemia to increase HKII mRNA indicates that insulin is likely a physiological regulator of HKII expression in human skeletal muscle in vivo. Copyright (C) 2000 by W.B. Saunders Company.

Original languageEnglish (US)
Pages (from-to)814-818
Number of pages5
JournalMetabolism: Clinical and Experimental
Volume49
Issue number6
StatePublished - 2000
Externally publishedYes

Fingerprint

Hexokinase
Skeletal Muscle
Insulin
Glycogen Synthase
Messenger RNA
Glucose Clamp Technique
Hyperinsulinism
Biopsy
Muscles
Glucose
Glucose-6-Phosphate
Ribonucleases
Healthy Volunteers
Protein Isoforms
Phosphorylation
RNA

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Vogt, C., Ardehali, H., Iozzo, P., Yki-Jarvinen, H., Koval, J., Maezono, K., ... Mandarino, L. (2000). Regulation of hexokinase II expression in human skeletal muscle in vivo. Metabolism: Clinical and Experimental, 49(6), 814-818.

Regulation of hexokinase II expression in human skeletal muscle in vivo. / Vogt, C.; Ardehali, H.; Iozzo, P.; Yki-Jarvinen, H.; Koval, J.; Maezono, K.; Pendergrass, M.; Printz, R.; Granner, D.; DeFronzo, R.; Mandarino, L.

In: Metabolism: Clinical and Experimental, Vol. 49, No. 6, 2000, p. 814-818.

Research output: Contribution to journalArticle

Vogt, C, Ardehali, H, Iozzo, P, Yki-Jarvinen, H, Koval, J, Maezono, K, Pendergrass, M, Printz, R, Granner, D, DeFronzo, R & Mandarino, L 2000, 'Regulation of hexokinase II expression in human skeletal muscle in vivo', Metabolism: Clinical and Experimental, vol. 49, no. 6, pp. 814-818.
Vogt C, Ardehali H, Iozzo P, Yki-Jarvinen H, Koval J, Maezono K et al. Regulation of hexokinase II expression in human skeletal muscle in vivo. Metabolism: Clinical and Experimental. 2000;49(6):814-818.
Vogt, C. ; Ardehali, H. ; Iozzo, P. ; Yki-Jarvinen, H. ; Koval, J. ; Maezono, K. ; Pendergrass, M. ; Printz, R. ; Granner, D. ; DeFronzo, R. ; Mandarino, L. / Regulation of hexokinase II expression in human skeletal muscle in vivo. In: Metabolism: Clinical and Experimental. 2000 ; Vol. 49, No. 6. pp. 814-818.
@article{413f0109ee3d43cbb8ce97e771a347af,
title = "Regulation of hexokinase II expression in human skeletal muscle in vivo",
abstract = "The phosphorylation of glucose to glucose-6-phosphate (G-6-P) is the first committed step in glucose uptake in skeletal muscle. This reaction is catalyzed by hexokinase (HK). Two HK isoforms, HKI and HKII, are expressed in human skeletal muscle, but only HKII is regulated by insulin. The present study was undertaken to determine the time course for the regulation of HK activity and expression by physiological plasma insulin concentrations in human skeletal muscle in vivo. A hyperinsulinemic-euglycemic glucose clamp and percutaneous muscle biopsy were performed in separate groups of healthy subjects after 60, 120, 180, and 360 minutes of euglycemic hyperinsulinemia. Muscle biopsies were subfractionated into soluble and particulate fractions to determine HKI and HKII activities. RNA was extracted from a separate portion of the muscle biopsy, and HKI and HKII mRNA content was determined using an RNase protection assay. Glycogen synthase (GS) activity and fractional velocity were also determined. HKII mRNA was increased 2-fold by 120 minutes and remained high versus the basal value for up to 360 minutes. HKI mRNA was unchanged throughout the study. HKII activity increased after 360 minutes of insulin infusion, and this increase was limited to the soluble fraction. In contrast, insulin induced a 1.5- to 2-fold increase in GS fractional velocity that was sustained for 360 minutes. The time course of the ability of hyperinsulinemia to increase HKII mRNA indicates that insulin is likely a physiological regulator of HKII expression in human skeletal muscle in vivo. Copyright (C) 2000 by W.B. Saunders Company.",
author = "C. Vogt and H. Ardehali and P. Iozzo and H. Yki-Jarvinen and J. Koval and K. Maezono and M. Pendergrass and R. Printz and D. Granner and R. DeFronzo and L. Mandarino",
year = "2000",
language = "English (US)",
volume = "49",
pages = "814--818",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Regulation of hexokinase II expression in human skeletal muscle in vivo

AU - Vogt, C.

AU - Ardehali, H.

AU - Iozzo, P.

AU - Yki-Jarvinen, H.

AU - Koval, J.

AU - Maezono, K.

AU - Pendergrass, M.

AU - Printz, R.

AU - Granner, D.

AU - DeFronzo, R.

AU - Mandarino, L.

PY - 2000

Y1 - 2000

N2 - The phosphorylation of glucose to glucose-6-phosphate (G-6-P) is the first committed step in glucose uptake in skeletal muscle. This reaction is catalyzed by hexokinase (HK). Two HK isoforms, HKI and HKII, are expressed in human skeletal muscle, but only HKII is regulated by insulin. The present study was undertaken to determine the time course for the regulation of HK activity and expression by physiological plasma insulin concentrations in human skeletal muscle in vivo. A hyperinsulinemic-euglycemic glucose clamp and percutaneous muscle biopsy were performed in separate groups of healthy subjects after 60, 120, 180, and 360 minutes of euglycemic hyperinsulinemia. Muscle biopsies were subfractionated into soluble and particulate fractions to determine HKI and HKII activities. RNA was extracted from a separate portion of the muscle biopsy, and HKI and HKII mRNA content was determined using an RNase protection assay. Glycogen synthase (GS) activity and fractional velocity were also determined. HKII mRNA was increased 2-fold by 120 minutes and remained high versus the basal value for up to 360 minutes. HKI mRNA was unchanged throughout the study. HKII activity increased after 360 minutes of insulin infusion, and this increase was limited to the soluble fraction. In contrast, insulin induced a 1.5- to 2-fold increase in GS fractional velocity that was sustained for 360 minutes. The time course of the ability of hyperinsulinemia to increase HKII mRNA indicates that insulin is likely a physiological regulator of HKII expression in human skeletal muscle in vivo. Copyright (C) 2000 by W.B. Saunders Company.

AB - The phosphorylation of glucose to glucose-6-phosphate (G-6-P) is the first committed step in glucose uptake in skeletal muscle. This reaction is catalyzed by hexokinase (HK). Two HK isoforms, HKI and HKII, are expressed in human skeletal muscle, but only HKII is regulated by insulin. The present study was undertaken to determine the time course for the regulation of HK activity and expression by physiological plasma insulin concentrations in human skeletal muscle in vivo. A hyperinsulinemic-euglycemic glucose clamp and percutaneous muscle biopsy were performed in separate groups of healthy subjects after 60, 120, 180, and 360 minutes of euglycemic hyperinsulinemia. Muscle biopsies were subfractionated into soluble and particulate fractions to determine HKI and HKII activities. RNA was extracted from a separate portion of the muscle biopsy, and HKI and HKII mRNA content was determined using an RNase protection assay. Glycogen synthase (GS) activity and fractional velocity were also determined. HKII mRNA was increased 2-fold by 120 minutes and remained high versus the basal value for up to 360 minutes. HKI mRNA was unchanged throughout the study. HKII activity increased after 360 minutes of insulin infusion, and this increase was limited to the soluble fraction. In contrast, insulin induced a 1.5- to 2-fold increase in GS fractional velocity that was sustained for 360 minutes. The time course of the ability of hyperinsulinemia to increase HKII mRNA indicates that insulin is likely a physiological regulator of HKII expression in human skeletal muscle in vivo. Copyright (C) 2000 by W.B. Saunders Company.

UR - http://www.scopus.com/inward/record.url?scp=0034041702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034041702&partnerID=8YFLogxK

M3 - Article

C2 - 10877213

AN - SCOPUS:0034041702

VL - 49

SP - 814

EP - 818

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 6

ER -